Vaccinia Related Kinase 3 (VRK3)

[Edit]

Serine/threonine-protein pseudokinase VRK3; Inactive serine/threonine-protein kinase VRK3

Vaccinia Related Kinase 3 (VRK3)
VRK3encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. In both human and mouse, this gene has substitutions at several residues within the ATP binding motifs that in other kinases have been shown to be required for catalysis. In vitro assays indicate the protein lacks phosphorylation activity. The protein, however, likely retains its substrate binding capability. This gene is widely expressed in human tissues and its protein localizes to the nucleus. Alternative splicing results in multiple transcripts encoding different isoforms.
VRK3 is expressed in various other rodent tissues and in embryos, and regulates VHR phosphatase activity in these tissues. VHR–VRK3 complex is a phosphatase-active form.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Vaccinia Related Kinase 3 (VRK3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Vaccinia Related Kinase 3 (VRK3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Vaccinia Related Kinase 3 (VRK3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Vaccinia Related Kinase 3 (VRK3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Vaccinia Related Kinase 3 (VRK3) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Vaccinia Related Kinase 3 (VRK3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Vaccinia Related Kinase 3 (VRK3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Vaccinia Related Kinase 3 (VRK3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Vaccinia Related Kinase 3 (VRK3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Vaccinia Related Kinase 3 (VRK3) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Vaccinia Related Kinase 3 (VRK3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Vaccinia Related Kinase 3 (VRK3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Vaccinia Related Kinase 3 (VRK3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Vaccinia Related Kinase 3 (VRK3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Vaccinia Related Kinase 3 (VRK3) ELISA Kit Customized Service Offer
  1. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  2. "The DNA sequence and biology of human chromosome 19." Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Characterization of three paralogous members of the Mammalian vaccinia related kinase family."J. Biol. Chem. 279:7934-7946(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities."Mol. Cell. Proteomics 7:2199-2214(2008) [PubMed] [Europe PMC] [Abstract]
  6. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  7. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  8. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  9. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  10. "Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site."Structure 17:128-138(2009) [PubMed] [Europe PMC] [Abstract]
  11. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]